These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7649960)

  • 21. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects and noneffects of methylphenidate in children with mental retardation and ADHD.
    Handen BL; Breaux AM; Janosky J; McAuliffe S; Feldman H; Gosling A
    J Am Acad Child Adolesc Psychiatry; 1992 May; 31(3):455-61. PubMed ID: 1592777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylphenidate in hyperactive boys with comorbid tic disorder: II. Short-term behavioral effects in school settings.
    Gadow KD; Nolan EE; Sverd J
    J Am Acad Child Adolesc Psychiatry; 1992 May; 31(3):462-71. PubMed ID: 1592778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of sustained-release and standard preparations of methylphenidate on attention deficit disorder.
    Fitzpatrick PA; Klorman R; Brumaghim JT; Borgstedt AD
    J Am Acad Child Adolesc Psychiatry; 1992 Mar; 31(2):226-34. PubMed ID: 1564023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylphenidate treatment of attention-deficit hyperactivity disorder in boys with Tourette's syndrome.
    Sverd J; Gadow KD; Paolicelli LM
    J Am Acad Child Adolesc Psychiatry; 1989 Jul; 28(4):574-9; discussion 580-2. PubMed ID: 2768152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response.
    Newcorn JH; Kratochvil CJ; Allen AJ; Casat CD; Ruff DD; Moore RJ; Michelson D;
    Am J Psychiatry; 2008 Jun; 165(6):721-30. PubMed ID: 18281409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder.
    Wilens TE; McBurnett K; Bukstein O; McGough J; Greenhill L; Lerner M; Stein MA; Conners CK; Duby J; Newcorn J; Bailey CE; Kratochvil CJ; Coury D; Casat C; Denisco MJ; Halstead P; Bloom L; Zimmerman BA; Gu J; Cooper KM; Lynch JM
    Arch Pediatr Adolesc Med; 2006 Jan; 160(1):82-90. PubMed ID: 16389216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of response to methylphenidate among children with ADHD and mental retardation.
    Handen BL; Janosky J; McAuliffe S; Breaux AM; Feldman H
    J Am Acad Child Adolesc Psychiatry; 1994 Oct; 33(8):1185-93. PubMed ID: 7982869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-response effects of methylphenidate on academic performance and overt behavior in hyperactive children.
    Tannock R; Schachar RJ; Carr RP; Logan GD
    Pediatrics; 1989 Oct; 84(4):648-57. PubMed ID: 2780127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety.
    Tannock R; Ickowicz A; Schachar R
    J Am Acad Child Adolesc Psychiatry; 1995 Jul; 34(7):886-96. PubMed ID: 7649959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of methylphenidate on subtypes of attention-deficit/hyperactivity disorder.
    Gorman EB; Klorman R; Thatcher JE; Borgstedt AD
    J Am Acad Child Adolesc Psychiatry; 2006 Jul; 45(7):808-16. PubMed ID: 16832317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of theophylline compared to methylphenidate for the treatment of attention-deficit hyperactivity disorder in children and adolescents: a pilot double-blind randomized trial.
    Mohammadi MR; Kashani L; Akhondzadeh S; Izadian ES; Ohadinia S
    J Clin Pharm Ther; 2004 Apr; 29(2):139-44. PubMed ID: 15068402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ginkgo biloba for attention-deficit/hyperactivity disorder in children and adolescents: a double blind, randomized controlled trial.
    Salehi B; Imani R; Mohammadi MR; Fallah J; Mohammadi M; Ghanizadeh A; Tasviechi AA; Vossoughi A; Rezazadeh SA; Akhondzadeh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):76-80. PubMed ID: 19815048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temperament and character dimensions associated with clinical characteristics and treatment outcome in attention-deficit/hyperactivity disorder boys.
    Purper-Ouakil D; Cortese S; Wohl M; Aubron V; Orejarena S; Michel G; Asch M; Mouren MC; Gorwood P
    Compr Psychiatry; 2010; 51(3):286-92. PubMed ID: 20399338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensitivity to reward frequency in boys with attention deficit hyperactivity disorder.
    Tripp G; Alsop B
    J Clin Child Psychol; 1999 Sep; 28(3):366-75. PubMed ID: 10446686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aggressive, prosocial, and nonsocial behavior in hyperactive boys: dose effects of methylphenidate in naturalistic settings.
    Hinshaw SP; Henker B; Whalen CK; Erhardt D; Dunnington RE
    J Consult Clin Psychol; 1989 Oct; 57(5):636-643. PubMed ID: 2794184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of methylphenidate on reading in children with attention deficit disorder.
    Ballinger CT; Varley CK; Nolen PA
    Am J Psychiatry; 1984 Dec; 141(12):1590-3. PubMed ID: 6507665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylphenidate and cognitive perseveration in hyperactive children.
    Tannock R; Schachar R
    J Child Psychol Psychiatry; 1992 Oct; 33(7):1217-28. PubMed ID: 1400703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analog classroom assessment of Adderall in children with ADHD.
    Swanson JM; Wigal S; Greenhill LL; Browne R; Waslik B; Lerner M; Williams L; Flynn D; Agler D; Crowley K; Fineberg E; Baren M; Cantwell DP
    J Am Acad Child Adolesc Psychiatry; 1998 May; 37(5):519-26. PubMed ID: 9585654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder.
    Pelham WE; Murphy DA; Vannatta K; Milich R; Licht BG; Gnagy EM; Greenslade KE; Greiner AR; Vodde-Hamilton M
    J Consult Clin Psychol; 1992 Apr; 60(2):282-292. PubMed ID: 1592959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.